What Is Cascade?
About CASCADE
Developed in collaboration with and presented by global experts and thought leaders
CASCADE (Comprehensive Awareness Series for Cortisol-Associated Diseases Education) was launched in 2022 to address one of the greatest challenges in endocrinology: the substantial delay in recognizing and diagnosing hypercortisolism. Despite its serious impact on cardiometabolic, bone, immune, and neuropsychiatric health, hypercortisolism often goes unrecognized for years. CASCADE exists to change that reality by providing expert-led, unbranded education that helps clinicians detect the disease sooner and manage it with greater confidence.
Developed in collaboration with global thought leaders and presented at leading institutions across the United States, CASCADE offers practical, evidence-based learning modules, live programs, and faculty-led discussions. Each program is designed to highlight real-world clinical practices, share the latest insights, and equip healthcare professionals to spot subtle presentations, reduce diagnostic delays, and ultimately improve patient outcomes.
What makes CASCADE unique is its collaborative model: education delivered by experts, shaped by clinical experience, and shared within a community of peers. Since its inception, CASCADE has reached dozens of institutions nationwide, creating opportunities for meaningful dialogue between faculty and clinicians. By engaging with CASCADE, you join a growing network committed to advancing hypercortisolism awareness and elevating standards of care.
Dr. Heaney discusses the mission of CASCADE — to elevate awareness and recognition of hypercortisolism through expert-led education.
CASCADE Across the U.S.
Since 2022, CASCADE has partnered with leading institutions to deliver unbranded education on hypercortisolism